Clinical Trials in Pierre-Bénite, Lyon
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Diffuse Large B Cell Lymphoma
Karyopharm Therapeutics Inc244 enrolled176 locationsNCT02227251
Recruiting
Not Applicable
RhEumatoid Arthritis MEDIcation Adherence
Rheumatoid Arthritis
Hospices Civils de Lyon200 enrolled2 locationsNCT05413759